News|Articles|February 26, 2025
Advanced LC-MS Technology for Enhanced HCP Detection in Complex Biotherapeutics
Author(s)Samsung Biologics
The identification, characterization, and quantitation of host cell protein (HCP) impurities are a critical challenge in the biopharmaceutical industry. Advanced LC-MS techniques can be integrated into manufacturing workflows to mitigate risks and ensure higher product quality and improved patient safety.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
WEF Welcomes ACG Shirwal as First Pharma Packaging Site in Global Lighthouse Network
3
Women in STEM: Early Phase Drug Development
4
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
5